medline.ch Dermatologie Psoriasis
Leaderboard

En | De
Sie sind hier: Dermatologie » Psoriasis 18. Mai 2022
Suchen
medline.ch
Psoriasis
Erweiterte Suche
Dermatologie
Akne
Alopezie
Dermatitis
Infektionen
Photosensitive Erkrankungen
Psoriasis
Tumoren
Ulcus
Urtikaria
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 1039  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 20761  
   
Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2 - Management of Special Populations, Patients With Comorbid Conditions, and Risk.
Actas Dermosifiliogr
Carrascosa JM, Puig L, Romero IB, Salgado-Boquete L, Del Alcázar E, Lencina JJA, Moreno D, de la Cueva P.
PMID: 35570005 [PubMed - as supplied by publisher]


Real-world evidence from the non-interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumab.
J Eur Acad Dermatol Venereol
Gerdes S, Asadullah K, Hoffmann M, Korge B, Mortazawi D, Wegner S, Personke Y, Gomez M, Sticherling M.
PMID: 35569014 [PubMed - as supplied by publisher]


Retrospective study of apremilast drug survival in psoriasis patients in a daily practice setting: a long-term experience.
Dermatol Ther
Galache-Osuna C, Reyes-García S, Salgueiro E, Bordallo-Landa J, Lozano A, Vázquez-López F, Santos-Juanes J.
PMID: 35567525 [PubMed - as supplied by publisher]


Fatty Acid-Binding Protein 7 (FABP-7), Glutamic Acid and Neurofilament Light Chain (NFL) as Potential Markers of Neurodegenerative Disorders in Psoriatic Patients-A Pilot Study.
J Clin Med
Nowowiejska J, Baran A, Hermanowicz JM, Sieklucka B, Krahel JA, Kiluk P, Pawlak D, Flisiak I.
PMID: 35566558 [PubMed]


Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities.
J Clin Med
Campanati A, Diotallevi F, Martina E, Radi G, Offidani A.
PMID: 35566548 [PubMed]


Usefulness of Ultrasound Examination in the Assessment of the Nail Apparatus in Psoriasis.
Int J Environ Res Public Health
Krajewska-W, Owczarczyk-Saczonek A.
PMID: 35565018 [PubMed - in process]


Annoying Psoriasis and Atopic Dermatitis: A Narrative Review.
Int J Mol Sci
Chen WY, Chen SC, Hsu SY, Lin YA, Shih CM, Huang CY, Wang KH, Lee AW.
PMID: 35563285 [PubMed - indexed for MEDLINE]


Conventional Synthetic Disease-Modifying Anti-rheumatic Drugs for Psoriatic Arthritis: Findings and Implications From a Patient Centered Longitudinal Study in Brazil.
Front Pharmacol
Faria RJ, Cordeiro FJR, Dos Santos JBR, Alvares-Teodoro J, Guerra Júnior AA, Acurcio FA, da Silva MRR.
PMID: 35559237 [PubMed]


Cellular Molecular of Osteopontin in the Pathogenesis of Psoriasis.
FASEB J
Salleh MN, Hui Juan MO, Mustaffa MIR.
PMID: 35553740 [PubMed - indexed for MEDLINE]


IL-23 Monoclonal Antibodies for IBD: So Many, So Different?
J Crohns Colitis
McDonald BD, Dyer EC, Rubin DT.
PMID: 35553664 [PubMed - indexed for MEDLINE]


What Can IBD Specialists Learn from IL-23 Trials in Dermatology?
J Crohns Colitis
Valenti M, Narcisi A, Pavia G, Gargiulo L, Costanzo A.
PMID: 35553663 [PubMed - indexed for MEDLINE]


Do We Have a New Psoriasis Drug?
FASEB J
, Skroza N, Mangino G, , Seiwerth S, Sikiri.
PMID: 35552916 [PubMed - indexed for MEDLINE]


Secukinumab improves mild-to-moderate psoriasis: a randomized, placebo-controlled exploratory clinical trial.
J Am Acad Dermatol
Kim J, Lee J, Hawkes JE, Li X, Kunjravia N, Rambhia D, Cueto I, Moreno A, Hur H, Garcet S, Zhou W, Cao J, Krueger JG.
PMID: 35551962 [PubMed - as supplied by publisher]


Do Patients with Psoriatic Arthritis Have More Severe Skin Disease than Patients with Psoriasis Only? A Systematic Review and Meta-Analysis.
Dermatology
Pouw JN, Jacobs ME, Balak DMW, van Laar JM, Welsing PMJ, Leijten EFA.
PMID: 35551372 [PubMed - as supplied by publisher]


Economic Burden of Generalized Pustular Psoriasis in Sweden: A Population-Based Register Study.
Psoriasis (Auckl)
Löfvendahl S, Norlin JM, Schmitt-Egenolf M.
PMID: 35548662 [PubMed]


Minimal Physiologically-Based Pharmacokinetic (mPBPK) Metamodeling of Target Engagement in Skin Informs Anti-IL17A Drug Development in Psoriasis.
Front Pharmacol
Ayyar VS, Lee JB, Wang W, Pryor M, Zhuang Y, Wilde T, Vermeulen A.
PMID: 35548359 [PubMed]


Successful secukinumab treatment in focal segmental glomerulosclerosis associated with plaque psoriasis.
Ren Fail
Cao Z, Liu Z, Zhu X, Yang Q, Xu Q, Zhang C.
PMID: 35546261 [PubMed - indexed for MEDLINE]


Enabling precision monitoring of psoriasis treatment by optoacoustic mesoscopy.
Sci Transl Med
Hindelang B, Nau T, Englert L, Berezhnoi A, Lauffer F, Darsow U, Biedermann T, Eyerich K, Aguirre J, Ntziachristos V.
PMID: 35544596 [PubMed - indexed for MEDLINE]


Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis: Pooled Results From Phase 2 and Phase 3 Randomized Clinical Trials.
JAMA Dermatol
Gordon KB, Langley RG, Warren RB, Okubo Y, Stein Gold L, Merola JF, Peterson L, Wixted K, Cross N, Deherder D, Thaçi D.
PMID: 35544084 [PubMed - as supplied by publisher]


Health literacy and medication adherence in psoriasis patients: a survey in Iran.
BMC Prim Care
Avazeh Y, Rezaei S, Bastani P, Mehralian G.
PMID: 35538417 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 20761    Seite 1 von 1039  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1